European Medicines Agency recommends authorisation of additional vaccine for influenza pandemic (H1N1) 2009

The European Medicines Agency has recommended to the European Commission that an additional vaccine against influenza A(H1N1) (‘swine flu’), Celvapan from Baxter, be granted a marketing authorisation. Adoption of an authorisation decision by the European Commission is expected shortly. ... Read more